Strikingly, ctDNA responses after an individual cycle of ICI therapy distinguished nearly all DCB from NDB patients (Fig. a larger threat proportion in comparison to ctDNA or bTMB alone significantly. D) Percent of sufferers stratified by high bTMB/MB (14) and low bTMB/MB ( 14) in ICI sufferers that obtain DCB (n = 15) versus NDB … Continue reading Strikingly, ctDNA responses after an individual cycle of ICI therapy distinguished nearly all DCB from NDB patients (Fig